ADMS - Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q1 2021 Results - Earnings Call Transcript

Adamas Pharmaceuticals, Inc. (ADMS) Q1 2021 Earnings Conference Call May 10, 2021 4:30 PM ET Company Participants Peter Vozzo – Investor Relations Neil McFarlane – Chief Executive Officer Vijay Shreedhar – Chief Commercial Officer Chris Prentiss – Chief Financial Officer Adrian Quartel – Chief Medical Officer Conference Call Participants Marc Goodman – SVB Leerink Lachlan Hanbury-Brown – William Blair Jason Butler – JMP Securities Stacy Ku – Cowen & Co. Zack Sachar – Piper Sandler Presentation Operator Welcome to the Adamas Pharmaceuticals First Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead. Peter Vozzo Thank you, Paul, and good afternoon, everyone. On the call with me today are Neil McFarlane, Chief Executive Officer; Vijay Shreedhar, Chief Commercial Officer; and

For further details see:

Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q1 2021 Results - Earnings Call Transcript